知镜 Cognispect · 医学文献与研究工作台

Pulmonary embolism as the initial manifestation of acute promyelocytic leukemia: A case report and review of the literature.

Dong J, Zhai X.
Medicine · 2026-10-01 · PMID 43012828

文献摘要

Rationale Acute promyelocytic leukemia (APL) usually presents with bleeding-related coagulopathy. Pulmonary embolism (PE) before APL is recognized is uncommon and complicates anticoagulation. Patient concerns A 26-year-old obese man presented with progressive dyspnea, small-volume hemoptysis, and pleuritic chest pain. Diagnoses Computed tomography pulmonary angiography showed segmental PE in the right lower lobe. Leukocytosis, anemia, and severe thrombocytopenia prompted hematologic evaluation. Bone marrow morphology, t(15;17), and promyelocytic leukemia-retinoic acid receptor alpha confirmed high-risk APL. Interventions Nadroparin was started for PE. After APL was confirmed, all-trans retinoic acid, hydroxyurea, pirarubicin, and later arsenic trioxide were administered. Anticoagulation was reduced during bleeding and thrombocytopenia and later resumed with transfusion support. Outcomes Suspected differentiation syndrome resolved with dexamethasone. PE improved, but a splenic infarct developed during induction. Therapeutic anticoagulation was resumed after bleeding resolved. The patient achieved sustained molecular remission, complete radiologic resolution of PE, and no recurrent thrombosis during more than 2.5 years of follow-up. Lessons PE with unexplained cytopenias or leukocytosis should prompt smear review and urgent evaluation for APL. Confirmed thrombosis requires anticoagulation individualized to thrombus severity, bleeding, platelet and fibrinogen trends, and serial reassessment.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。